Evotec Se - Adr Share Price Today
(NASDAQ: EVO)

Name: Evotec Se - Adr Share Price Today (NASDAQ: EVO) - Evotec Se - Adr Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Evotec Se - Adr share price is $4.22 & ₹360.25 as on 26 Apr 2025, 2.30 'hrs' IST

$4.22

▲

0.01

(0.24%)

Market is closed - opens 7 PM, 28 Apr 2025

View live Evotec Se - Adr share price in Dollar and Rupees. Guide to invest in Evotec Se - Adr stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Evotec Se - Adr, along with analyst recommendations, forecasts, and comprehensive financials.

Evotec Se - Adr share price movements

Today's Low: $4.04
Today's High: $4.22
$4.22
4.27%
Downside
Day's Volatility :4.27%
Upside
0.0%
52 Weeks Low: $2.84
52 Weeks High: $5.68
$4.22
32.7%
Downside
52 Weeks Volatility :50.0%
Upside
25.7%

Evotec Se - Adr (EVO) Returns

Period	Evotec Se - Adr	Sector (Health Care)	Index (Russel 2000)
3 Months	-2.76%	-5.8%	0.0%
6 Months	9.33%	-7.2%	0.0%
1 Year	-18.85%	-1.4%	0.0%
3 Years	-64.83%	3.2%	-7.8%

Evotec Se - Adr (EVO) Key Statistics

in dollars & INR

Previous Close	$4.21
Open	$4.09
Today's High	$4.22
Today's Low	$4.04
Market Capitalization	$1.5B
Today's Volume	$21.0K
52 Week High	$5.68
52 Week Low	$2.84
Revenue TTM	$797.0M
EBITDA	$651.0K
Earnings Per Share (EPS)	$-0.63
Profit Margin	-24.6%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-18.92%

How to invest in Evotec Se - Adr Stock (EVO) from India?

It is very easy for Indian residents to invest directly in Evotec Se - Adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Evotec Se - Adr stock in both Indian Rupees (INR) and US Dollars (USD). Search for Evotec Se - Adr or EVO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Evotec Se - Adr or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Evotec Se - Adr shares which would translate to 0.202 fractional shares of Evotec Se - Adr as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Evotec Se - Adr, in just a few clicks!

Returns in Evotec Se - Adr (EVO) for Indian investors in Rupees

The Evotec Se - Adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Evotec Se - Adr investment value today

Current value as on today

₹83,604

Returns

₹16,396

(-16.4%)

Returns from Evotec Se - Adr Stock

₹18,846 (-18.85%)

Dollar Returns

₹2,451 (+2.45%)

Indian investors sentiment towards Evotec Se - Adr (EVO)

-24%

Period: Mar 28, 2025 to Apr 27, 2025. Change in 30 Days versus previous period

Search interest for Evotec Se - Adr Stock from India on INDmoney has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Evotec Se - Adr

Mubadala Investment Company PJSC
1.29%
Wellington Management Company LLP
0.65%
BlackRock Inc
0.41%
DCF Advisers, LLC
0.06%
Morgan Stanley - Brokerage Accounts
0.04%
Goldman Sachs Group Inc
0.02%

Analyst Recommendation on Evotec Se - Adr

Rating

Trend

Buy

87%Buy

12%Hold

0%Sell

Based on 16 Wall street analysts offering stock ratings for Evotec Se - Adr(by analysts ranked 0 to 5 stars)

Analyst Forecast on Evotec Se - Adr Stock (EVO)

What analysts predicted

Upside of 53.47%

Target:

$6.48

Current:

$4.22

Insights on Evotec Se - Adr Stock (Ticker Symbol: EVO)

Price Movement
In the last 7 days, EVO stock has moved up by 17.3%
Increasing Revenue
Revenue is up for the last 4 quarters, 182.12M → 221.22M (in $), with an average increase of 6.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -39.63M → -40.83M (in $), with an average decrease of 1.5% per quarter
EVO vs UTHR (1 yr)
In the last 1 year, United Therapeutics Corporation has given 24.6% return, outperforming this stock by 40.9%
EVO vs UTHR (3 yr)
In the last 3 years, United Therapeutics Corporation has given 62.4% return, outperforming this stock by 128.2%
Price to Sales
ForEVO every $1 of sales, investors are willing to pay $1.9, whereas for United Therapeutics Corporation, the investors are paying $4.6 for every $1 of sales.

Evotec Se - Adr Technicals Summary

Sell

Neutral

Buy

Evotec Se - Adr is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Evotec Se - Adr (EVO) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Evotec Se - Adr	26.35%	9.33%	-18.85%	-64.83%	-80.82%
United Therapeutics Corporation	-5.51%	-16.68%	22.29%	64.1%	63.86%
Zoetis Inc.	-6.75%	-16.03%	-3.9%	-13.42%	22.24%
Haleon Plc Spon Ads	-1.02%	2.0%	20.19%	37.38%	37.38%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Evotec Se - Adr	485.75	NA	NA	-0.31	-0.19	-0.02	NA	5.37
United Therapeutics Corporation	11.82	11.82	1.43	27.3	0.19	0.12	NA	143.74
Zoetis Inc.	28.11	28.11	2.71	6.09	0.51	0.15	0.01	10.64
Haleon Plc Spon Ads	24.55	24.24	1.79	0.41	0.09	0.05	0.02	1.79

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Evotec Se - Adr	Buy	$1.5B	-80.82%	485.75	-24.6%
United Therapeutics Corporation	Buy	$13.3B	63.86%	11.82	41.53%
Zoetis Inc.	Buy	$68.5B	22.24%	28.11	26.86%
Haleon Plc Spon Ads	Buy	$46.5B	37.38%	24.55	12.84%

About Evotec Se - Adr

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. It operates in two segments, Shared R&D and Just " Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, fibrosis, immunology, pain and inflammation, infectious, kidney, liver, rare, respiratory, fibrotic and metabolic disease; central nervous system (CNS) and cardio-metabolic disorders; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. It also has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB; Bayer, Novo Nordisk, Eli Lilly, and Novartis company for kidney disease; and Sandoz, patient advocacy groups, and venture capital, as well as a strategic research collaboration agreement with Bristol Myers Squibb to build a molecular glue-based pipeline for unmet medical needs. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Organization	Evotec Se - Adr
Employees	4740
CEO	Dr. Christian Wojczewski Ph.D.
Industry	Miscellaneous

Management People of Evotec Se - Adr

Name	Title
Dr. Christian Wojczewski Ph.D.	CEO & Management Board Member
Dr. Cord Dohrmann Ph.D.	Chief Scientific Officer & Member of Management Board
Ms. Aurelie Dalbiez	Chief People Officer & Member of Management Board
Mr. Paul Hitchin	Chief Financial Officer
Mr. Volker Braun	Executive VP and Head of Global Investor Relations & ESG
Dr. Christian Dargel	EVP Global Head of Legal & Compliance
Dr. Ian M. Hunneyball	Senior Vice President of Programme Management & Clinical Operations
Dr. David Hallet	Executive Vice President
Uwe Andag	EVP Head of Metabolic Diseases
Ms. Christiane Honisch	SVP Head of Diagnostics

Important FAQs about investing in EVO Stock from India :

What is Evotec Se - Adr share price today?

Evotec Se - Adr share price today stands at $4.22, Open: $4.09 ; Previous Close: $4.21 ; High: $4.22 ; Low: $4.04 ; 52 Week High: $5.68 ; 52 Week Low: $2.84.

The stock opens at $4.09, after a previous close of $4.21. The stock reached a daily high of $4.22 and a low of $4.04, with a 52-week high of $5.68 and a 52-week low of $2.84.

Can Indians buy Evotec Se - Adr shares?

Yes, Indians can invest in the Evotec Se - Adr (EVO) from India.

With INDmoney, you can buy Evotec Se - Adr at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Evotec Se - Adr at zero transaction cost.

How can I buy Evotec Se - Adr shares from India?

It is very easy to buy Evotec Se - Adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Evotec Se - Adr (EVO) be purchased?

Yes, you can buy fractional shares of Evotec Se - Adr with INDmoney app.

What are the documents required to start investing in Evotec Se - Adr stocks?

To start investing in Evotec Se - Adr, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.